Ultracet (Tramadol HCL [37.5 mg]/Acetaminophen [325 mg]) Combination Tablets in the Treatment of the Pain of Fibromyalgia

Trial Profile

Ultracet (Tramadol HCL [37.5 mg]/Acetaminophen [325 mg]) Combination Tablets in the Treatment of the Pain of Fibromyalgia

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2013

At a glance

  • Drugs Tramadol/paracetamol (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 01 Jul 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Actual initiation date (May 2008) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top